In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Questions Arise As To Whether Chinese Price Cut Fears Are Overstated

This article was originally published in The Pink Sheet Daily

Executive Summary

Volume likely to drive pharma industry growth, analysts say.

You may also be interested in...



China's NDRC Releases First Set Of Price Cuts; MNCs See Deepest Cuts As Expected

SHANGHAI - China's National Development and Reform Commission has released long-awaited price cuts that will mostly affect multinational pharma companies

China Boosts Health System Reforms With Expanded National Drug Reimbursement List

BEIJING - In the government's latest move to expand coverage under sweeping health system reforms that are in the works China-wide, the Ministry of Human Resources and Social Security has added hundreds of new medicines to the latest edition of the national drug reimbursement catalog

China Releases First Part Of Essential Drug List For Community Health Clinics And Rural Hospitals

SHANGHAI - China's Ministry Of Health released Aug. 18 the first part of the essential drug list for community health organizations, which consists of 205 chemical drugs and biologics as well as 102 traditional Chinese Medicines. The implementation will begin Sept. 21 in 30 percent of the government-run low-tier hospitals and clinics

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071659

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel